Mitchell P. Kopin 13D/13G Filings for SENECA BIOPHARMA INC (SNCA)

Mitchell P. Kopin 13D and 13G filings for SENECA BIOPHARMA INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-29
06:05 am
Purchase
2020-12-31 13G SENECA BIOPHARMA INC
SNCA
Mitchell P. Kopin 1,176,852
6.400%
759,851increase
(+182.22%)
Filing